Danda Trouve Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Danda Trouve Investment Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$20K	Hold	70	–	–	0.04%	70
2022 Q2	$20K	Hold	70	–	–	0.03%	60
2022 Q1	$18K	Hold	70	–	–	0.02%	72
2021 Q4	$15K	Hold	70	–	–	0.02%	93
2021 Q3	$13K	Hold	70	–	–	0.02%	112
2021 Q2	$14K	Hold	70	–	–	0.02%	105
2021 Q1	$15K	Hold	70	–	–	0.02%	82
2020 Q4	$17K	Hold	70	–	–	0.02%	88
2020 Q3	$19K	Hold	70	–	–	0.03%	87
2020 Q2	$20K	Hold	70	–	–	0.03%	75
2020 Q1	$17K	Hold	70	–	–	0.04%	81
2019 Q4	$15K	Buy	+70	New	+$14.2K	0.02%	94

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Danda Trouve Investment Management's VRTX Position: Q3 2022 in Review

Danda Trouve Investment Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2022 at 70 shares worth $20K. The position accounts for 0.04% of the portfolio, ranked #70.

Danda Trouve Investment Management first reported a position in VRTX in Q4 2019 and has held it in 12 quarters since. 1,124 funds tracked by Wall St. Rank hold VRTX as of Q3 2022.

Danda Trouve Investment Management held 70 shares of Vertex Pharmaceuticals worth $20K as of Q3 2022.
Danda Trouve Investment Management left its Vertex Pharmaceuticals share count unchanged in Q3 2022.
Vertex Pharmaceuticals made up 0.04% of Danda Trouve Investment Management's portfolio in Q3 2022, its #70 holding.
Danda Trouve Investment Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 12 quarters since.
1,124 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2022.

Based on Danda Trouve Investment Management's 13F filing for Q3 2022, filed 14 Oct 2022.